Post

Therapeutics take forever to make, and that can leave people feeling frustrated with where their tax dollars are going. So this is a new series where we clue you into the history of breakthroughs, one story at a time.

To start off, we will be taking a look at cancer, a disease that affects most people and is where a substantial amount of investments is made.

Meet Ras! Ras is a protein that can turn cell growth on and off and has been a target for cancer therapeutics for decades. Just yesterday, it was announced that the FDA has approved the first ever ras-targeted therapeutic!

Most people have no idea how incremental science is and how much of the work does not lead to anything currently useful

I live in the autoimmune world. The difference in available medications from when my dad was diagnosed with RA in the late 60s to what I am now on for psoriatic arthritis and Crohn's is amazing. I'd be severely disabled if not for the drugs that came out in the last 30 years.